Search
for
Sort by
Research 6
- Side Effects and Adverse Events After Treatment With Teprotumumab for Thyroid Eye Disease: A Retrospective Observational Case Series
- Medications affecting the insulin-like growth factor 1/growth hormone axis, including teprotumumab, somatostatin analogs, and anti-calcitonin gene-related peptide monoclonal antibodies, are associated with elevated reporting odds of alopecia in women: A pharmacovigilance study
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Construction of the coexpression network involved in the pathogenesis of thyroid eye disease via bioinformatics analysis
- Resolution of advanced conjunctival squamous cell carcinoma with cemiplimab immunotherapy, IFNα-2b, and retinoic acid treatment over 2 years of follow-up
- Dermatologic manifestations of thyroid disease: a literature review